Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
2(17%)
Results Posted
40%(2 trials)
Terminated
2(17%)

Phase Distribution

Ph early_phase_1
1
8%
Ph not_applicable
5
42%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(5)
Terminated(2)
Other(3)

Detailed Status

Completed5
Terminated2
Active, not recruiting2
unknown2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
71.4%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (16.7%)
N/A5 (83.3%)

Trials by Status

completed542%
suspended18%
terminated217%
active_not_recruiting217%
unknown217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
PROCEDURE
Total Trials
12